The higher rate of mastectomy among breast cancer patients imaged with MRI may be due to selection bias as opposed to the modality itself, according to a study presented at the RSNA scientific assembly Nov. 28.
The higher rate of mastectomy among breast cancer patients imaged with MRI may be due to selection bias as opposed to the modality itself, according to a study presented at the RSNA scientific assembly Nov. 28.
There has been much debate within the scientific community about whether breast MRI increases the rate of mastectomy. Some researchers say MRI leads to more mastectomies while others argue other factors influence the suggestion.
“From our retrospective data we cannot determine the impact of MRI as a single factor regarding surgical planning, and neither can we define a causal association between breast MRI and mastectomy,” said Dr. Fabio Chiesa, from the University of Genova in Genoa, Italy, and presenter of the study.
The researchers reviewed five years of information in the electronic database of their institution to determine whether the use of breast MRI for preoperative staging of breast cancer was associated with an increased mastectomy rate. They found preoperative staging MRI was performed in 105 patients. The mastectomy rate for the total number of performed surgical treatments fluctuated by year from 13% to 21.4% with no discernible pattern emerging.
The overall rate of mastectomies for the period from 2003 to 2008 was 17.1%. The stratified mastectomy rate was 37.1% for the patients who underwent preoperative MRI and 14.6% for the patients staged without MRI.
The higher mastectomy rate in patients who performed preoperative MRI can be easily explained by the preferred use of preoperative MRI in patients with a higher suspicion of extensive disease at clinical examination and conventional imaging such as mammography and sonography, Chiesa said.
“In conclusion, according to our experience, breast MRI can be implemented in clinical practice for preoperative treatment planning without significantly increasing the overall mastectomy rate,” he said.
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.